Table 5. Favorable donor characteristics³⁴⁾.

Age (<55 years)
Absence of significant structural abnormalities such as:
	LV hypertrophy (wall thickness >13 mm by echocardiography)
	Significant valvular dysfunction
	Significant congenital cardiac abnormality
	Significant coronary artery disease
Adequate physiologic function of donor heart
	LVEF ≥45% or
	Achievement of target hemodynamic criteria after hormonal resuscitation and hemodynamic management
	MAP >60 mmHg
	PCWP 8–12 mmHg
	Cardiac index >2.4 L/min·m2
	CVP 4–12 mmHg
	SVR 800–1200 dyne/s·cm5
No inotrope dependence
Donor-recipient body size match (usually within 20–30% of height and weight)
Negative hepatitis C antibody, hepatitis B surface antigen, and HIV serologies absence of active malignancy (except nonmelanoma skin cancers and certain primary brain tumors) or overwhelming infection

CNS = central nervous system; CVP = central venous pressure; LV = left ventricle; LVEF = left ventricle ejection fraction; MAP = mean arterial pressure; pCO2: partial pressure of carbon dioxide.; PCWP: pulmonary capillary wedge pressure; SVR: systemic vascular resistance

^*Removal of CNS-depressing drugs may take several days to take effect.